$2.54
0.124.96%
Pre-Market: 4:44 AM EDT
15 minutes delayed
Revance Therapeutics
RVNCNASDAQ
Revance Therapeutics (NASDAQ:RVNC) Stock, Earnings Estimates, EPS, And Revenue
Revance Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 9
EPS
$-0.540
Quarterly Revenue
$51.9M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$240.2M
Analyze the earnings history of Revance Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| RVNC | Revance Therapeutics | -$0.80 | — | — | — | $58.13M | — | — | — | 08/06/2024 | Get Alert |
| RVNC | Revance Therapeutics | -$0.60 | -$0.75 | -$0.54 | 28.00% | $49.33M | $56.63M | $51.94M | -8.29% | 05/09/2024 | Get Alert |
| RVNC | Revance Therapeutics | -$1.82 | -$0.72 | -$0.62 | 13.89% | $49.92M | $62.63M | $69.80M | 11.45% | 02/28/2024 | Get Alert |
| RVNC | Revance Therapeutics | -$1.17 | -$0.90 | -$0.55 | 38.89% | $29.02M | $60.38M | $56.78M | -5.97% | 11/08/2023 | Get Alert |
| RVNC | Revance Therapeutics | -$0.88 | -$0.77 | -$0.80 | -3.90% | $28.37M | $59.35M | $58.13M | -2.05% | 08/08/2023 | Get Alert |
| RVNC | Revance Therapeutics | -$0.94 | -$0.70 | -$0.74 | -5.71% | $25.26M | $46.10M | $49.33M | 7.01% | 05/09/2023 | Get Alert |
| RVNC | Revance Therapeutics | -$0.93 | -$0.95 | -$1.82 | -91.58% | $25.95M | $46.55M | $49.92M | 7.24% | 02/28/2023 | Get Alert |
| RVNC | Revance Therapeutics | -$1.10 | -$0.89 | -$1.17 | -31.46% | $19.75M | $27.94M | $29.02M | 3.85% | 11/08/2022 | Get Alert |
| RVNC | Revance Therapeutics | -$1.07 | -$0.86 | -$0.88 | -2.33% | $18.80M | $28.45M | $28.37M | -0.29% | 08/09/2022 | Get Alert |
| RVNC | Revance Therapeutics | -$1.08 | -$0.91 | -$0.94 | -3.30% | $13.30M | $24.01M | $25.26M | 5.21% | 05/10/2022 | Get Alert |
| RVNC | Revance Therapeutics | -$1.24 | -$1.02 | -$0.93 | 8.82% | $11.13M | $24.27M | $25.95M | 6.92% | 02/28/2022 | Get Alert |
| RVNC | Revance Therapeutics | -$1.34 | -$1.15 | -$1.10 | 4.35% | $3.83M | $20.29M | $19.75M | -2.69% | 11/09/2021 | Get Alert |
| RVNC | Revance Therapeutics | -$1.12 | -$1.05 | -$1.07 | -1.90% | $299.00K | $15.48M | $18.80M | 21.47% | 08/05/2021 | Get Alert |
| RVNC | Revance Therapeutics | -$1.15 | -$1.09 | -$1.08 | 0.92% | $58.00K | $10.98M | $13.30M | 21.12% | 05/10/2021 | Get Alert |
| RVNC | Revance Therapeutics | -$0.99 | -$1.24 | -$1.24 | 0.00% | $89.00K | $8.78M | $11.13M | 26.80% | 02/22/2021 | Get Alert |
| RVNC | Revance Therapeutics | -$0.96 | -$1.03 | -$1.34 | -30.10% | $46.00K | $1.78M | $3.83M | 115.45% | 11/09/2020 | Get Alert |
| RVNC | Revance Therapeutics | -$0.86 | -$1.01 | -$1.12 | -10.89% | $0.00 | $450.00K | $299.00K | -33.56% | 08/06/2020 | Get Alert |
| RVNC | Revance Therapeutics | -$0.85 | -$0.90 | -$1.15 | -27.78% | $278.00K | $170.00K | $58.00K | -65.88% | 05/07/2020 | Get Alert |
| RVNC | Revance Therapeutics | -$1.12 | -$0.98 | -$0.99 | -1.02% | $487.00K | $2.29M | $89.00K | -96.11% | 02/24/2020 | Get Alert |
| RVNC | Revance Therapeutics | -$0.91 | -$0.98 | -$0.96 | 2.04% | $2.36M | $430.00K | $46.00K | -89.30% | 11/04/2019 | Get Alert |
| RVNC | Revance Therapeutics | -$0.94 | -$0.91 | -$0.86 | 5.49% | $686.00K | $710.00K | $0.00 | -100.00% | 08/05/2019 | Get Alert |
Revance Therapeutics (RVNC) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-09 | $-0.54 | $-0.75 | 28.0 % |
| Dec 2023 | 2024-02-28 | $-0.62 | $-0.72 | 13.9 % |
| Sep 2023 | 2023-11-08 | $-0.55 | $-0.90 | 38.9 % |
| Jun 2023 | 2023-08-08 | $-0.80 | $-0.77 | -3.90 % |
Revance Therapeutics (RVNC) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-09 | $51.94M | $56.63M | -8.29 % |
| Dec 2023 | 2024-02-28 | $69.80M | $62.63M | 11.5 % |
| Sep 2023 | 2023-11-08 | $56.78M | $60.38M | -5.97 % |
| Jun 2023 | 2023-08-08 | $58.13M | $59.35M | -2.05 % |
FAQ
When is Revance Therapeutics (NASDAQ:RVNC) reporting earnings?
Revance Therapeutics (RVNC) is scheduled to report earnings on August 6, 2024. The last reported earnings were for reported on May 9, 2024 for Q1.
What were the latest earnings per share (EPS) for Revance Therapeutics (NASDAQ:RVNC)?
The Actual EPS was $-0.54, which beat the estimate of $-0.75.
What were Revance Therapeutics’s (NASDAQ:RVNC) revenues?
The Actual Revenue was $51.9M, which missed the estimate of $56.6M.
Browse earnings estimates, EPS, and revenue on all stocks.